Mitochondrial determinants of chemoresistance

Abstract

Chemoresistance constitute nowadays the major contributor to therapy failure in most cancers. There are main factors that mitigate cell response to therapy, such as target organ, inherent sensitivity to the administered compound, its metabolism, drug efflux and influx or alterations on specific cellular targets, among others. We now know that intrinsic properties of cancer cells, including metabolic features, substantially contribute to chemoresistance. In fact, during the last years, numerous reports indicate that cancer cells resistant to chemotherapy demonstrate significant alterations in mitochondrial metabolism, membrane polarization and mass. Metabolic activity and expression of several mitochondrial proteins are modulated under treatment to cope with stress, making these organelles central players in the development of resistance to therapies. Here, we review the role of mitochondria in chemoresistant cells in terms of metabolic rewiring and function of key mitochondria-related proteins.

Keywords

Mitochondria / chemoresistance / oxidative phosphorylation / fatty acid oxidation / metabolism / uncoupling proteins / ABC transporters

References

[1] Warburg O,Negelein E.The metabolism of tumors in the body..J Gen Physiol1927;8:519-30 PMCID:PMC2140820

[2] Pedersen PL.Tumor mitochondria and the bioenergetics of cancer cells..Prog Exp Tumor Res1978;22:190-274

[3] Pavlova NN.The emerging hallmarks of cancer metabolism..Cell Metab2016;23:27-47 PMCID:PMC4715268

[4] Weinberg SE.Targeting mitochondria metabolism for cancer therapy..Nat Chem Biol2015;11:9 PMCID:PMC4340667

[5] Wallace DC.Mitochondria and cancer..Nat Rev Cancer2012;12:685-98 PMCID:PMC4371788

[6] Vyas S,Haigis MC.Mitochondria and cancer..Cell2016;166:555-66 PMCID:PMC5036969

[7] Spinelli JB.The multifaceted contributions of mitochondria to cellular metabolism..Nat Cell Biol2018;20:745-54 PMCID:PMC6541229

[8] Cluntun AA,Cerione RA.Glutamine metabolism in cancer: understanding the Heterogeneity..Trends Cancer2017;3:169-80 PMCID:PMC5383348

[9] Lukey MJ,Cerione RA.Targeting amino acid metabolism for cancer therapy..Drug Discov Today2017;22:796-804 PMCID:PMC5429979

[10] DeBerardinis RJ.Fundamentals of cancer metabolism..Sci Adv2016;2:e1600200 PMCID:PMC4928883

[11] Gentric G,Mechta-Grigoriou F.Heterogeneity in cancer metabolism: new concepts in an old field..Antioxid Redox Signal2017;26:462-85 PMCID:PMC5359687

[12] Evans JMM,Emslie-Smith AM,Morris AD.Metformin and reduced risk of cancer in diabetic patients..BMJ2005;330:1304-5 PMCID:PMC558205

[13] Bayraktar S,Lei X,Litton JK.Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer..Cancer2012;118:1202-11 PMCID:PMC3207034

[14] Bodmer M,Meier C,Meier CR.Use of metformin and the risk of ovarian cancer: a case-control analysis..Gynecol Oncol2011;123:200-4

[15] Wheaton WW,Hamanaka RB,Sullivan LB.Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis..Elife2014;3:e02242 PMCID:PMC4017650

[16] Jagust P,Parejo-Alonso B.Metabolism-based therapeutic strategies targeting cancer stem cells..Front Pharmacol2019;10:203 PMCID:PMC6438930

[17] Heeschen C.More challenges ahead-metabolic heterogeneity of pancreatic cancer stem cells..Mol Cell Oncol2016;3:e1105353 PMCID:PMC4905405

[18] Sancho P,Tavera A,Jagust P.MYC/PGC-1alpha balance determines the metabolic phenotype and plasticity of pancreatic cancer stem cells..Cell Metab2015;22:590-605

[19] Zhou G,Li Y,Shen X.Role of AMP-activated protein kinase in mechanism of metformin action..J Clin Invest2001;108:1167-74 PMCID:PMC209533

[20] Griss T,Egnatchik R,Ma EH.Metformin antagonizes cancer cell proliferation by suppressing mitochondrial-dependent biosynthesis..PLoS Biol2015;13:e1002309 PMCID:PMC4666657

[21] Wang Y,Ruan Y,Chu Q.Coordinative metabolism of glutamine carbon and nitrogen in proliferating cancer cells under hypoxia..Nat Commun2019;10:201 PMCID:PMC6331631

[22] Kim JH,Seo Y,Yoon JP.Effects of metformin on colorectal cancer stem cells depend on alterations in glutamine metabolism..Sci Rep2018;8:409 PMCID:PMC5765079

[23] Shackelford DB,Gerken L,Seki A.LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin..Cancer Cell2013;23:143-58 PMCID:PMC3579627

[24] Márquez J,Matés JM,Martín-Rufián M.Glutamine Addiction In Gliomas..Neurochem Res2017;42:1735-46

[25] Mohamed A,Khuri FR.Altered glutamine metabolism and therapeutic opportunities for lung cancer..Clin Lung Cancer2014;15:7-15 PMCID:PMC3970234

[26] Gao P,Chang TC,Kita K.c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism..Nature2009;458:762 PMCID:PMC2729443

[27] Gross MI,Dennison JB,Chernov-Rogan T.Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer..Mol Cancer Ther2014;13:890-901

[28] Qie S,Li W,Sang N.ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation..J Cell Biochem2014;115:498-509 PMCID:PMC4518873

[29] Erickson JW.Glutaminase: a hot spot for regulation of cancer cell metabolism?.Oncotarget2010;1:734-40 PMCID:PMC3018840

[30] Son J,Ying H,Hua S.Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway..Nature2013;496:101 PMCID:PMC3656466

[31] Seltzer MJ,Joshi AD,Thomas AG.Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1..Cancer Res2010;70:8981-7 PMCID:PMC3058858

[32] Tanaka K,Irino Y,Nagashima H.Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment..J Clin Invest2015;125:1591-602 PMCID:PMC4396477

[33] Masamha CP.Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy..J Cell Biochem2018;119:6136-45

[34] Wang J-B,Fuji R,Gao P.Targeting mitochondrial glutaminase activity inhibits oncogenic transformation..Cancer Cell2010;18:207-19 PMCID:PMC3078749

[35] Cheng T,Yang C,Jin ES.Pyruvate carboxylase is required for glutamine-independent growth of tumor cells..Proc Natl Acad Sci U S A2011;108:8674-9 PMCID:PMC3102381

[36] Christa L,Flinois JP,Brechot C.Overexpression of glutamine synthetase in human primary liver cancer..Gastroenterology1994;106:1312-20

[37] Issaq SH,Fox SD.Glutamine synthetase is necessary for sarcoma adaptation to glutamine deprivation and tumor growth..Oncogenesis2019;8:20 PMCID:PMC6391386

[38] Yang L,Yeung TL,Jiang D.Targeting stromal glutamine synthetase in tumors disrupts tumor microenvironment-regulated cancer cell growth..Cell Metab2016;24:685-700

[39] Kung HN,Chi JT.Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia..PLoS Genet2011;7:e1002229 PMCID:PMC3154963

[40] Kuo CY.When fats commit crimes: fatty acid metabolism, cancer stemness and therapeutic resistance..Cancer Commun (Lond)2018;38:47 PMCID:PMC6042406

[41] Mancini R,Pisanu ME,Maugeri-Saccà M.Metabolic features of cancer stem cells: the emerging role of lipid metabolism..Oncogene2018;37:2367

[42] Yi M,Chen S,Ban Y.Emerging role of lipid metabolism alterations in Cancer stem cells..J Exp Clin Cancer Res2018;37:118 PMCID:PMC6003041

[43] Menendez JA.Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis..Nat Rev Cancer2007;7:763-77

[44] Schcolnik-Cabrera A,Dominguez-Gomez G,Morales-Barcenas R.Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy..Expert Opin Investig Drugs2018;27:475-89

[45] Flavin R,Nguyen PL.Fatty acid synthase as a potential therapeutic target in cancer..Future Oncol2010;6:551-62 PMCID:PMC3197858

[46] Papaevangelou E,Box C,Chung YL.The effect of FASN inhibition on the growth and metabolism of a cisplatin-resistant ovarian carcinoma model..Int J Cancer2018;143:992-1002 PMCID:PMC6055739

[47] Zaytseva YY,Le AT,Flight RM.Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer..Oncotarget2018;9:24787-800 PMCID:PMC5973868

[48] Nieman KM,Penicka CV,Buell-Gutbrod R.Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth..Nat Med2011;17:1498-503 PMCID:PMC4157349

[49] Alcalá AM.BRAF inhibitors for the treatment of metastatic melanoma: clinical trials and mechanisms of resistance..Clin Cancer Res2012;18:33-9

[50] Baenke F,Smith M,Hogan K.Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells..Mol Oncol2016;10:73-84 PMCID:PMC4717845

[51] Corazao-Rozas P,Jendoubi M,Jonneaux A.Mitochondrial oxidative stress is the Achille’s heel of melanoma cells resistant to Braf-mutant inhibitor..Oncotarget2013;4:1986-98 PMCID:PMC3875764

[52] Hernandez-Davies JE,Reid MA,Lowman XH.Vemurafenib resistance reprograms melanoma cells towards glutamine dependence..J Transl Med2015;13:210 PMCID:PMC4490757

[53] Serkova N.Detection of resistance to Imatinib by metabolic profiling..Am J Pharmacogenomic2005;5:293-302

[54] Kluza J,Ballot C,Jonneaux A.Exploiting mitochondrial dysfunction for effective elimination of Imatinib-resistant leukemic cells..PLoS One2011;6:e21924 PMCID:PMC3138741

[55] Liu W,Wang XT,Dan X.Overcoming 5-Fu resistance of colon cells through inhibition of Glut1 by the specific inhibitor WZB117..Asian Pac J Cancer Prev2014;15:7037-41

[56] Shin YK,Chang HJ,Hong SH.Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance..Cancer Res2005;65:3162-70

[57] Denise C,Calvani M,Giannoni E.5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits..Oncotarget2015;6:41706-21 PMCID:PMC4747183

[58] Vellinga TT,Boer VCJ de,van Schelven S.SIRT1/PGC1α-dependent increase in oxidative phosphorylation supports chemotherapy resistance of colon cancer..Clin Cancer Res2015;21:2870-9

[59] Sancho P,Heeschen C.Hallmarks of cancer stem cell metabolism..Br J Cancer2016;114:1305-12 PMCID:PMC4984474

[60] Jagust P,Parejo-Alonso B.Metabolism-based therapeutic strategies targeting cancer stem cells..Front Pharmacol2019;10:203 PMCID:PMC6438930

[61] He W,Wang C,Zhao Y.MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer..Oncogene2019;38:4637

[62] Liang XJ,Shen DW,Aszalos A.SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabolism..Mol Cancer Res2008;6:1499-506 PMCID:PMC2597364

[63] Xu Y,Zhang Y,Liu Y.ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells..Int J Oncol2018;53:1055-68 PMCID:PMC6065457

[64] Matassa DS,Lu H,Arzeni D.Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer..Cell Death Differ2016;23:1542 PMCID:PMC5072430

[65] Zhu J,Song L,Tan Z.NKX2-8 deletion-induced reprogramming of fatty acid metabolism confers chemoresistance in epithelial ovarian cancer..EBioMedicine2019;43:238-52 PMCID:PMC6562195

[66] Li J,Zhou X,Zhao L.Inhibition of lipolysis by Mercaptoacetate and Etomoxir specifically sensitize drug-resistant lung adenocarcinoma cell to Paclitaxel..PLoS One2013;8:e74623 PMCID:PMC3770579

[67] Freiburghaus C,Johansson A,Ek F.Resistance to cytarabine in mantle cell lymphoma is mediated by down-regulation of deoxycytidine kinase at the protein level..Blood2016;128:1769

[68] Lokody I.Drug resistance: overcoming resistance in acute myeloid leukaemia treatment..Nat Rev Cancer2014;14:452-3

[69] Farge T,Toni Fd,Hosseini M.Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism..Cancer Discov2017;7:716-35 PMCID:PMC5501738

[70] Carretero MV,Latasa U,Prieto J.Transformed but not normal hepatocytes express UCP2..FEBS Lett1998;439:55-8

[71] Giatromanolaki A,Kalamida D,Sivridis E.Thermogenic protein UCP1 and UCP3 expression in non-small cell lung cancer: relation with glycolysis and anaerobic metabolism..Cancer Biol Med2017;14:396-404 PMCID:PMC5785172

[72] Horimoto M,Konkin TA,Wands JR.Expression of uncoupling protein-2 in human colon cancer..Clin Cancer Res2004;10:6203-7

[73] Klingenberg M.Uncoupling protein--a useful energy dissipator..J Bioenerg Biomembr1999;31:419-30

[74] Baffy G.Uncoupling protein-2 and cancer..Mitochondrion2010;10:243-52

[75] Samudio I,Andreeff M.Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism..Cancer Res2009;69:2163-6 PMCID:PMC3822436

[76] Baffy G.Mitochondrial uncoupling in cancer cells: liabilities and opportunities..Biochim Biophys Acta Bioenerg2017;1858:655-64

[77] Derdak Z,Beldi G,Wands JR.The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells..Cancer Res2008;68:2813-9 PMCID:PMC2386271

[78] Nedergaard J.The ‘novel’ ‘uncoupling’ proteins UCP2 and UCP3: what do they really do? Pros and cons for suggested functions..Exp Physiol2003;88:65-84

[79] Pecqueur C,Ricquier D.UCP2, a metabolic sensor coupling glucose oxidation to mitochondrial metabolism?.IUBMB Life2009;61:762-7

[80] Koziel A,Jarmuszkiewicz W.Increased activity of mitochondrial uncoupling protein 2 improves stress resistance in cultured endothelial cells exposed in vitro to high glucose levels..Am J Physiol Heart Circ Physiol2015;309:H147-56

[81] Dalla Pozza E,Dando I,Sgarbossa A.Role of mitochondrial uncoupling protein 2 in cancer cell resistance to gemcitabine..BBA-Mol Cell Res2012;1823:1856-63

[82] Mailloux RJ,Harper ME.Genipin-induced inhibition of uncoupling protein-2 sensitizes drug-resistant cancer cells to cytotoxic agents..PLoS One2010;5:e13289 PMCID:PMC2953501

[83] Collins P,Choudhury S,Hodgson H.Increased expression of uncoupling protein 2 in HepG2 cells attenuates oxidative damage and apoptosis..Liver Int2005;25:880-7

[84] Liu WY,Li H.Exhaustive training increases uncoupling protein 2 expression and decreases Bcl-2/Bax ratio in rat skeletal muscle..Oxid Med Cell Longev2013;2013:23365696 PMCID:PMC3556863

[85] Deng S,Han Y,Wang X.UCP2 inhibits ROS-mediated apoptosis in A549 under hypoxic conditions..PLoS One2012;7:e30714 PMCID:PMC3265501

[86] Cox J.Mechanisms of doxorubicin resistance in hepatocellular carcinoma..Hepat Oncol2016;3:57-9 PMCID:PMC4792121

[87] Elliott AM.ABCB8 mediates doxorubicin resistance in melanoma cells by protecting the mitochondrial genome..Mol Cancer Res2009;7:79-87

[88] Szakács G,Ludwig JA,Gottesman MM.Targeting multidrug resistance in cancer..Nat Rev Drug Discov2006;5:219

[89] Chuthapisith S,El-Sheemey M.Breast cancer chemoresistance: emerging importance of cancer stem cells..Surg Oncol2010;19:27-32

[90] Eyre R,Stemke-Hale K,Tyson-Capper A.Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population..Tumor Biol2014;35:9879-92

[91] Begicevic RR.ABC transporters in cancer stem cells: beyond chemoresistance..Int J Mol Sci2017;18:2362 PMCID:PMC5713331

[92] Adamska A.ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?.World J Gastroenterol2018;24:3222-38 PMCID:PMC6079284

[93] Kubota N,Takeda Y,Funayama Y.Characterization of an etoposide-resistant human ovarian cancer cell line..Cancer Chemother Pharmacol1994;34:183-90

[94] Alpsoy A,Gunduz U.Etoposide resistance in MCF-7 breast cancer cell line is marked by multiple mechanisms..Biomed Pharmacother2014;68:351-5

[95] Solazzo M,D’Amico M,Tani A.Mitochondrial expression and functional activity of breast cancer resistance protein in different multiple drug-resistant cell lines..Cancer Res2009;69:7235-42

[96] Green DR.Mitochondria and apoptosis..Science1998;281:1309-12

[97] Wang X,Reed JC.The expanding role of mitochondria in apoptosis..Genes Dev1998;281:1309-12

[98] Liu R,Beidler DR,Núñez G.Overexpression of Bcl-xL promotes chemotherapy resistance of mammary tumors in a syngeneic mouse model..Am J Pathol1999;155:1861-7 PMCID:PMC1866947

[99] Tu Y,Liu J,Berenson J.Upregulated expression of BCL-2 in multiple myeloma cells induced by exposure to doxorubicin, etoposide, and hydrogen peroxide..Blood1996;88:1805-12

[100] Kutuk O.Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737..Cancer Res2008;68:7985-94 PMCID:PMC2603173

[101] Kang MH.Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy..Clin Cancer Res2009;15:1126-32 PMCID:PMC3182268

[102] Adams JM.The Bcl-2 apoptotic switch in cancer development and therapy..Oncogene2007;26:1324-37 PMCID:PMC2930981

[103] Sartorius UA.Upregulation of bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines..Int J Cancer2002;97:584-92

[104] Real PJ,Juan Ad,Lopez-Vega JM.Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells..Oncogene2002;21:7611

[105] Bauer JJ,Mostofi FK,Srivastava S.Elevated levels of apoptosis regulator proteins P53 and BCL-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer..J Urology1996;156:1511-6

[106] Cho HJ,Kim KD,Cho MY.Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells..Cancer Lett2006;237:56-66

[107] Amundson SA,Scudiero D,Reed JC.An informatics approach identifying markers of chemosensitivity in human cancer cell lines..Cancer Res2000;60:6101-10

[108] Biswas G,Avadhani NG.Mitochondria-to-nucleus stress signaling in mammalian cells: nature of nuclear gene targets, transcription regulation, and induced resistance to apoptosis..Gene2005;354:132-9 PMCID:PMC3800739

[109] Colié S,Kedjouar B,Albinet V.Disruption of Sphingosine 1-Phosphate Lyase confers resistance to chemotherapy and promotes oncogenesis through Bcl-2/Bcl-xL upregulation..Cancer Res2009;69:9346-53

[110] Renault TT,Bharti A.B cell lymphoma-2 (BCL-2) homology domain 3 (BH3) mimetics demonstrate differential activities dependent upon the functional repertoire of pro- and anti-apoptotic BCL-2 family proteins..J Biol Chem2014;289:26481-91 PMCID:PMC4176207

[111] Vogler M,Dyer MJS.Bcl-2 inhibitors: small molecules with a big impact on cancer therapy..Cell Death Differ2009;16:360

[112] Tse C,Adickes J,Chen J.ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor..Cancer Res2008;68:3421-8

[113] Oltersdorf T,Shoemaker AR,Augeri DJ.An inhibitor of Bcl-2 family proteins induces regression of solid tumours..Nature2005;435:677-81

[114] Samudio I,Fiegl M,Konopleva M.Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction..J Clin Invest2010;120:142-56 PMCID:PMC2799198

[115] Steele TM,Sam A,Ghosh PM.Obatoclax, a BH3 mimetic, enhances cisplatin-induced apoptosis and decreases the clonogenicity of muscle invasive bladder cancer cells via mechanisms that involve the inhibition of pro-survival molecules as well as cell cycle regulators..Int J Mol Sci2019;20:1285 PMCID:PMC6470498

[116] Luca A de,Peiris-Pagès M,Smith DL.Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells..Oncotarget2015;6:14777-95 PMCID:PMC4558115

[117] Salem AF,Howell A,Lisanti MP.Mitochondrial biogenesis in epithelial cancer cells promotes breast cancer tumor growth and confers autophagy resistance..Cell Cycle2012;11:4174-80 PMCID:PMC3524213

[118] Carracedo A,Leliaert AK,Boer VCJ de.A metabolic prosurvival role for PML in breast cancer..J Clin Invest2012;122:3088-100 PMCID:PMC3433768

[119] Martinez-Outschoorn UE,Sotgia F.Mitochondrial biogenesis drives tumor cell proliferation..Am J Pathol2011;178:1949-52 PMCID:PMC3081148

[120] Haq R,Andreu-Perez P,Edelman H.Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF..Cancer Cell2013;23:302-15 PMCID:PMC3635826

[121] Puigserver P,Park CW,Wright M.A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis..Cell1998;92:829-39

[122] Lin J,Spiegelman BM.Metabolic control through the PGC-1 family of transcription coactivators..Cell Metab2005;1:361-70

[123] Tan Z,Xiao L,Bode AM.The role of PGC1α in cancer metabolism and its therapeutic implications..Mol Cancer Ther2016;15:774-82

[124] Shin SW,Park ES,Kwak JY.Overexpression of PGC-1α enhances cell proliferation and tumorigenesis of HEK293 cells through the upregulation of Sp1 and Acyl-CoA binding protein..Int J Oncol2015;46:1328-42

[125] Bhalla K,Dewi RE,Twaddel W.PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis..Cancer Res2011;71:6888-98 PMCID:PMC3282487

[126] Srivastava S,Moraes CT.PGC-1alpha/beta upregulation is associated with improved oxidative phosphorylation in cells harboring nonsense mtDNA mutations..Hum Mol Genet2007;16:993-1005 PMCID:PMC2652746

[127] Kim B,Jung J,Suh DH.PGC1α induced by reactive oxygen species contributes to chemoresistance of ovarian cancer cells..Oncotarget2017;8:60299-311 PMCID:PMC5601140

[128] Gopal YNV,Chen G,Frederick DT.Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1alpha and oxidative phosphorylation in melanoma..Cancer Res2014;74:7037-47 PMCID:PMC4347853

[129] Gabrielson M,Carlson J.Expression of mitochondrial regulators PGC1α and TFAM as putative markers of subtype and chemoresistance in epithelial ovarian carcinoma..PLoS One2014;9:e107109 PMCID:PMC4170973

[130] Luo C,Puigserver P.PGC-1 coactivators: shepherding the mitochondrial biogenesis of tumors..Trends Cancer2016;2:619-31 PMCID:PMC5465638

[131] Yun CW,Lee SH.PGC-1α controls mitochondrial biogenesis in drug-resistant colorectal cancer cells by regulating endoplasmic reticulum stress..Int J Mol Sci2019;20:1707 PMCID:PMC6480203

[132] Douarre C,Dalla Rosa I,Redon CE.Mitochondrial Topoisomerase I is critical for mitochondrial integrity and cellular energy metabolism..PLoS One2012;7:e41094 PMCID:PMC3401127

[133] Kluza J,Gallego MA,Fournier C.Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells..Oncogene2004;23:7018

[134] Fu X,Lyu YL,Qi H.Etoposide Induces ATM-dependent mitochondrial biogenesis through AMPK activation..PLoS One2008;3:e2009 PMCID:PMC2329593

[135] Farnie G,Lisanti MP.High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant..Oncotarget2015;6:30472-86 PMCID:PMC4741545

[136] Haq R,Andreu-Perez P,Edelman H.Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF..Cancer Cell2013;23:302-15 PMCID:PMC3635826

[137] Lamb R,Ozsvári B,Fiorillo M.Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: understanding WNT/FGF-driven anabolic signaling..Oncotarget2015;6:30453-71 PMCID:PMC4741544

[138] Rose PG,Fusco N,Eaton S.Gemcitabine reverses cisplatin resistance: demonstration of activity in platinum- and multidrug-resistant ovarian and peritoneal carcinoma..Gynecol Oncol2003;88:17-21

[139] Rudin CM,Schumaker LM,Newkirk K.Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance..Cancer Res2003;63:312-8